ExL’s 3rd Clinical Site Feasibility, Selection and Startup will examine examples of effective communication processes between trial sponsors and sites leading to clear expectations and execution of research activity.
The performance measurement of sites provides sponsors and CROs with valuable data, however, the feedback from sites on what makes a sponsor attractive to work with has also been proven to be a valuable source of efficiency and communication for the process.
Study start-up, enrollment, and quality data will be areas of focus and global considerations will be examined to find out exactly how research is conducted and the preparation needed for cultural differences.
Top Five Reasons To Attend This Conference
- Learn the newest tips on identifying excellent sites and make a start-up meeting ROCK!
- Enhance your knowledge on dealing with non performing sites.
- What tactics work to entice sites to quickly open studies and enroll?
- How to “talk” to your stake-holder to avoid delays and create efficiency.
- Break down the barriers between Sponsors, CRO’s and Sites.
Who Should Attend
This Summit is specifically designed for C-Level Executives, Department Heads, Vice Presidents, Directors, and Managers at Pharmaceutical, Biotechnology, and Medical Device companies from the following departments:
- Clinical Operations
- Clinical Research/Development
- Trial Optimization
- Site Selection
- Protocol Feasibility
- Investigator Recruitment
- Patient Enrollment/Recruitment
- Site Monitoring/Management
- Clinical Data Analyst/Informatics Analyst
- Clinical Quality Assurance
- Clinical Project/Study Managers
- CRA’s Regulatory Affairs
- Medical Affairs
This conference is also of interest to Senior Level Representatives from Sites and Representatives responsible for Feasibility, Site Selection, Trial Optimization, and Patient Recruitment at CRO’s
